Trailing-twelve-month (TTM) revenue is $18.09 Billion with a year-over-year growth of +11.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,793,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $4,896,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $4,315,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $4,083,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $18,087,000,000 |
Current P/S: $57,912,313,300 market capitalization ÷ $18,087,000,000 TTM revenue = 3.20x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T17:20:31.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.08B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T17:20:31.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Aflac Japan Member | $15.4B | $14.9B | $12.3B | $10.7B | $9.7B | $9.4B |
| Aflac US Member | $6.6B | $6.5B | $6.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Aflac Japan Member | $9.4B |
| Aflac US Member | $6.9B |
$18.09B
$18.09 Billion
+11.62%
vs. $16.20B a year ago (TTM)
(4.64%)
5 Year compound annual growth rate
1 Year
+11.62%
3 Year
(1.17%)
5 Year
(4.64%)
10 Year
(1.58%)
15 Year
(0.96%)
20 Year
+1.11%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.44B | ($1.69B) | (8.84%) |
| 2024 | $19.13B | +$287.00M | +1.52% |
| 2023 | $18.84B | ($310.00M) | (1.62%) |
| 2022 | $19.15B | ($2.40B) | (11.12%) |
| 2021 | $21.55B | ($715.00M) | (3.21%) |
| 2020 |
TTM Growth
+11.62%
3-Year CAGR
(1.17%)
5-Year CAGR
(4.64%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6.7B |
| $6.9B |
| Other Segments | $384M | $175M | $267M | $460M | $1.0B | $1.3B |
|---|
| $22.26B |
| +$20.00M |
| +0.09% |
| 2019 | $22.24B | +$533.00M | +2.46% |
| 2018 | $21.71B | +$108.00M | +0.50% |
| 2017 | $21.60B | ($889.00M) | (3.95%) |
| 2016 | $22.49B | +$1.68B | +8.06% |
